Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20331733rdf:typepubmed:Citationlld:pubmed
pubmed-article:20331733lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:20331733lifeskim:mentionsumls-concept:C0001792lld:lifeskim
pubmed-article:20331733lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:20331733lifeskim:mentionsumls-concept:C0024501lld:lifeskim
pubmed-article:20331733lifeskim:mentionsumls-concept:C0026764lld:lifeskim
pubmed-article:20331733lifeskim:mentionsumls-concept:C1282910lld:lifeskim
pubmed-article:20331733lifeskim:mentionsumls-concept:C0444956lld:lifeskim
pubmed-article:20331733lifeskim:mentionsumls-concept:C1831743lld:lifeskim
pubmed-article:20331733lifeskim:mentionsumls-concept:C1515568lld:lifeskim
pubmed-article:20331733pubmed:issue6lld:pubmed
pubmed-article:20331733pubmed:dateCreated2010-6-29lld:pubmed
pubmed-article:20331733pubmed:abstractTextWith the aim to address the issue whether high-dose therapy (HDT) is required after new drugs combinations to improve outcome of elderly newly diagnosed multiple myeloma (MM) patients, we compared the toxicity and the outcome of ThaDD plus maintenance to those of ThaDD plus HDT-autologous stem cell transplantation (ASCT).lld:pubmed
pubmed-article:20331733pubmed:languageenglld:pubmed
pubmed-article:20331733pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20331733pubmed:citationSubsetIMlld:pubmed
pubmed-article:20331733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20331733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20331733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20331733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20331733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20331733pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20331733pubmed:statusMEDLINElld:pubmed
pubmed-article:20331733pubmed:monthJunlld:pubmed
pubmed-article:20331733pubmed:issn1600-0609lld:pubmed
pubmed-article:20331733pubmed:authorpubmed-author:VisaniGiusepp...lld:pubmed
pubmed-article:20331733pubmed:authorpubmed-author:LeoniPietroPlld:pubmed
pubmed-article:20331733pubmed:authorpubmed-author:GalieniPieroPlld:pubmed
pubmed-article:20331733pubmed:authorpubmed-author:OffidaniMassi...lld:pubmed
pubmed-article:20331733pubmed:authorpubmed-author:CorvattaLaura...lld:pubmed
pubmed-article:20331733pubmed:authorpubmed-author:BurattiniMaur...lld:pubmed
pubmed-article:20331733pubmed:authorpubmed-author:MontanariMaur...lld:pubmed
pubmed-article:20331733pubmed:authorpubmed-author:BrunoriMarino...lld:pubmed
pubmed-article:20331733pubmed:authorpubmed-author:CenturioniRic...lld:pubmed
pubmed-article:20331733pubmed:authorpubmed-author:FalcioniSadia...lld:pubmed
pubmed-article:20331733pubmed:authorpubmed-author:CatariniMassi...lld:pubmed
pubmed-article:20331733pubmed:authorpubmed-author:AlesianiFranc...lld:pubmed
pubmed-article:20331733pubmed:authorpubmed-author:PolloniClaudi...lld:pubmed
pubmed-article:20331733pubmed:authorpubmed-author:FraticelliPao...lld:pubmed
pubmed-article:20331733pubmed:authorpubmed-author:GentiliSilvia...lld:pubmed
pubmed-article:20331733pubmed:authorpubmed-author:SamoriArduino...lld:pubmed
pubmed-article:20331733pubmed:authorpubmed-author:SaviniAgneseAlld:pubmed
pubmed-article:20331733pubmed:authorpubmed-author:RuggieriMiria...lld:pubmed
pubmed-article:20331733pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20331733pubmed:volume84lld:pubmed
pubmed-article:20331733pubmed:ownerNLMlld:pubmed
pubmed-article:20331733pubmed:authorsCompleteYlld:pubmed
pubmed-article:20331733pubmed:pagination474-83lld:pubmed
pubmed-article:20331733pubmed:meshHeadingpubmed-meshheading:20331733...lld:pubmed
pubmed-article:20331733pubmed:meshHeadingpubmed-meshheading:20331733...lld:pubmed
pubmed-article:20331733pubmed:meshHeadingpubmed-meshheading:20331733...lld:pubmed
pubmed-article:20331733pubmed:meshHeadingpubmed-meshheading:20331733...lld:pubmed
pubmed-article:20331733pubmed:meshHeadingpubmed-meshheading:20331733...lld:pubmed
pubmed-article:20331733pubmed:meshHeadingpubmed-meshheading:20331733...lld:pubmed
pubmed-article:20331733pubmed:meshHeadingpubmed-meshheading:20331733...lld:pubmed
pubmed-article:20331733pubmed:meshHeadingpubmed-meshheading:20331733...lld:pubmed
pubmed-article:20331733pubmed:meshHeadingpubmed-meshheading:20331733...lld:pubmed
pubmed-article:20331733pubmed:meshHeadingpubmed-meshheading:20331733...lld:pubmed
pubmed-article:20331733pubmed:meshHeadingpubmed-meshheading:20331733...lld:pubmed
pubmed-article:20331733pubmed:meshHeadingpubmed-meshheading:20331733...lld:pubmed
pubmed-article:20331733pubmed:meshHeadingpubmed-meshheading:20331733...lld:pubmed
pubmed-article:20331733pubmed:meshHeadingpubmed-meshheading:20331733...lld:pubmed
pubmed-article:20331733pubmed:meshHeadingpubmed-meshheading:20331733...lld:pubmed
pubmed-article:20331733pubmed:meshHeadingpubmed-meshheading:20331733...lld:pubmed
pubmed-article:20331733pubmed:meshHeadingpubmed-meshheading:20331733...lld:pubmed
pubmed-article:20331733pubmed:meshHeadingpubmed-meshheading:20331733...lld:pubmed
pubmed-article:20331733pubmed:meshHeadingpubmed-meshheading:20331733...lld:pubmed
pubmed-article:20331733pubmed:year2010lld:pubmed
pubmed-article:20331733pubmed:articleTitleThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo multiple myeloma.lld:pubmed
pubmed-article:20331733pubmed:affiliationClinica di Ematologia Azienda Ospedaliero-Universitaria, Ospedali Riuniti di Ancona, Ancona. m.offidani@ospedaliriuniti.marche.itlld:pubmed
pubmed-article:20331733pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20331733pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed